NCT04448561View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

September 11, 2020

Study Completion Date

September 11, 2020

Conditions

Opioid Use Disorder

Interventions

DRUG

ASP8082

oral

DRUG

morphine

oral

DRUG

Placebo

oral

Trial Locations (1)

66212

Altasciences Clinical Kansas, Inc., Overland Park

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT04448561 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants | Biotech Hunter | Biotech Hunter